Literature DB >> 11897576

Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum.

Samuel Bellais1, Thierry Naas, Patrice Nordmann.   

Abstract

Antibiotic susceptibility testing by disk diffusion of a Chryseobacterium gleum isolate, strain CIP 103039, showed a typical synergy image between clavulanic acid and expanded-spectrum cephalosporins. Shotgun cloning gave a recombinant plasmid in Escherichia coli that produced a beta-lactamase, CGA-1, with a pI value of 8.9 that conferred resistance to most penicillins (except ureidopenicillins) and narrow-spectrum cephalosporins and an intermediate susceptibility to expanded-spectrum cephalosporins and aztreonam. The CGA-1 amino acid sequence shared only 60% amino acid identity with CME-1 and CME-2 from Chryseobacterium meningosepticum, the most closely related beta-lactamases. CGA-1 was very likely chromosome encoded. It is a novel member of the PER subgroup of Ambler class A beta-lactamases (Bush functional group 2be).

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11897576      PMCID： PMC127090          DOI： 10.1128/AAC.46.4.966-970.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.

Authors:  L Poirel; I Le Thomas; T Naas; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens.

Authors:  J W Decousser; L Poirel; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  The high resolution crystal structure for class A beta-lactamase PER-1 reveals the bases for its increase in breadth of activity.

Authors:  S Tranier; A T Bouthors; L Maveyraud; V Guillet; W Sougakoff; J P Samama
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

4.  Isolation of large bacterial plasmids and characterization of the P2 incompatibility group plasmids pMG1 and pMG5.

Authors:  J B Hansen; R H Olsen
Journal:  J Bacteriol       Date:  1978-07       Impact factor: 3.490

5.  Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections.

Authors:  Y Siegman-Igra; D Schwartz; G Soferman; N Konforti
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

6.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

7.  TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.

Authors:  J Silva; C Aguilar; G Ayala; M A Estrada; U Garza-Ramos; R Lara-Lemus; L Ledezma
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

8.  Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases.

Authors:  G M Rossolini; N Franceschini; L Lauretti; B Caravelli; M L Riccio; M Galleni; J M Frère; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

9.  Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum.

Authors:  S Bellais; L Poirel; T Naas; D Girlich; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

10.  Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes.

Authors:  S Bellais; L Poirel; S Leotard; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191
View more
  11 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  TLA-2, a novel Ambler class A expanded-spectrum beta-lactamase.

Authors:  Delphine Girlich; Laurent Poirel; Andreas Schlüter; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

Review 3.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Characterization of CIA-1, an Ambler class A extended-spectrum β-lactamase from Chryseobacterium indologenes.

Authors:  Takehisa Matsumoto; Mika Nagata; Nau Ishimine; Kenji Kawasaki; Kazuyoshi Yamauchi; Eiko Hidaka; Eriko Kasuga; Kazuki Horiuchi; Kozue Oana; Yoshiyuki Kawakami; Takayuki Honda
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

5.  RAA Enzyme Is a New Family of Class A Extended-Spectrum β-Lactamase from Riemerella anatipestifer Strain RCAD0122.

Authors:  Hongyan Luo; Dekang Zhu; Mengru Li; Yunhan Tang; Wenyu Zhang; Haoju Wang; Pei Li
Journal:  Antimicrob Agents Chemother       Date:  2022-01-03       Impact factor: 5.938

6.  Identification and Biosynthesis of Pro-Inflammatory Sulfonolipids from an Opportunistic Pathogen Chryseobacterium gleum.

Authors:  Lukuan Hou; Hai-Yan Tian; Li Wang; Zachary E Ferris; Junfeng Wang; Mingwei Cai; Ethan A Older; Manikanda Raja Keerthi Raja; Dan Xue; Wanyang Sun; Prakash Nagarkatti; Mitzi Nagarkatti; Hexin Chen; Daping Fan; Xiaoyu Tang; Jie Li
Journal:  ACS Chem Biol       Date:  2022-04-27       Impact factor: 4.634

7.  EBR-1, a novel Ambler subclass B1 beta-lactamase from Empedobacter brevis.

Authors:  Samuel Bellais; Delphine Girlich; Amal Karim; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

Authors:  Jeffrey T Kirby; Helio S Sader; Timothy R Walsh; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Genetic and biochemical characterization of CGB-1, an Ambler class B carbapenem-hydrolyzing beta-lactamase from Chryseobacterium gleum.

Authors:  Samuel Bellais; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Chryseobacterium gleum pneumonia in an infant with nephrotic syndrome.

Authors:  Baha Abdalhamid; Nasreldin Elhadi; Khaldoon Alsamman; Reem Aljindan
Journal:  IDCases       Date:  2016-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.